-

PACS Group Announces Appointment of Evelyn Dilsaver to Serve as Independent Board Director

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. “We’re thrilled to have Evelyn join our board,” said Jason Murray, PACS Chairman and CEO. “She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She’ll bring added perspective and expertise to the board as we work to guide PACS going forward.”

“I’m excited to join the PACS Board and assist the company in continuing its mission to provide quality skilled nursing care. I look forward to great things ahead for the company,” added Ms. Dilsaver.

Ms. Dilsaver also serves on the boards of directors of Tempur Sealy International (NYSE: TPX), HealthEquity, Inc. (Nasdaq: HQY) and QuidelOrtho (Nasdaq: QDEL). Ms. Dilsaver was President and Chief Executive Officer of Charles Schwab Investment Management from July 2004 until September 2007. Prior to that, she held various senior management positions with The Charles Schwab Corporation. Ms. Dilsaver is a certified public accountant and holds a B.S. degree in accounting from California State University-Hayward.

Ms. Dilsaver is an independent director under applicable NYSE and SEC rules. Her appointment now makes the PACS Board of Directors majority independent. Ms. Dilsaver’s committee appointments will be considered at a later date.

About PACS Group

PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. Founded in 2013, PACS Group is one of the largest post-acute platforms in the United States. Its independent subsidiaries operate over 200 post-acute care facilities across nine states serving over 20,000 patients daily.

Contacts

Brooks Stevenson
VP, Corporate Communication
801-597-9538 | Brooks.Stevenson@pacs.com

PACS Group, Inc.

NYSE:PACS

Release Versions

Contacts

Brooks Stevenson
VP, Corporate Communication
801-597-9538 | Brooks.Stevenson@pacs.com

More News From PACS Group, Inc.

PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the fiscal year and fourth quarter of 2025. Full Year 2025 Financial Highlights Revenue was $5.29 billion, an increase of 29.3% over prior year. Net income was $191.5 million. Adjusted EBITDA was $505.0 million. Adjusted EBITDAR was $883.9 million. Fourth Quarter...

PACS Group Intends to Release Fiscal Year and Fourth Quarter 2025 Earnings on February 26, 2026

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its fiscal year and fourth quarter 2025 financial results after market close on Thursday, February 26, 2026. Management will host a call on Thursday, February 26, 2026, at 5:30 p.m. ET to discuss the financial results and related information. PACS Group...

PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the...
Back to Newsroom